Objectives

After participating in this educational activity, attendees should be able to:

1|Describe the pharmacokinetic and pharmacodynamic changes associated with obesity.
2|Discuss clinical implications and potential outcomes of under-dosing or over-dosing common antimicrobials obesity.
3|Identify key challenges in optimizing antimicrobial dosing for obese patients.

 

Presenter(s): 
Chrystal Cardoza, PharmD
PGY2 Infectious Diseases Pharmacy Resident
Baystate Medical Center
NameRoleFinancial Relationship DisclosuresDiscussion of
Unlabeled/Unapproved Uses of
Drugs/Devices in Presentation?
Chrystal Cardoza, PharmDSpeaker/AuthorNo relevant relationships with ineligible companies to discloseNo
Session date: 
03/10/2025 - 2:00pm to 3:00pm EDT
Add to calendar: 
  • 1.00 ACPE Contact Hours
  • 1.00 ACPE Technician contact hours

Please login or register to take this course.